ReviewCancer research2019

A Tumor Agnostic Therapeutic Strategy for Hexokinase 1-Null/Hexokinase 2-Positive Cancers.

Shili Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.